SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-21-041467
Filing Date
2021-02-12
Accepted
2021-02-12 16:06:57
Documents
2
Group Members
ANSBERT GADICKELUKE EVNINMPM ASSET MANAGEMENT INVESTORS BV4 LLCMPM BIOVENTURES IV GMBH & CO. BETEILIGUNGS KGMPM BIOVENTURES IV GP LLCMPM BIOVENTURES IV LLCMPM BIOVENTURES IV STRATEGIC FUND, L.P.TODD FOLEY

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d133911dsc13ga.htm SC 13G/A 153689
2 EX-99.A d133911dex99a.htm EX-99.A 16861
  Complete submission text file 0001193125-21-041467.txt   172404
Mailing Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116
Business Address 200 CLARENDON STREET, 54TH FLOOR BOSTON MA 02116 617-425-9200
MPM BioVentures IV QP LP (Filed by) CIK: 0001358309 (see all company filings)

IRS No.: 204217788 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE BUILDING D, FLOOR 3 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Subject) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89449 | Film No.: 21627252
SIC: 2834 Pharmaceutical Preparations